Functional neuroimaging endpoints in drug development

A Otte*, K Audenaert, K Peremans, RA Dierckx

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    1 Citation (Scopus)
    Original languageEnglish
    Pages (from-to)755-756
    Number of pages2
    JournalNuclear Medicine Communications
    Volume26
    Issue number9
    Publication statusPublished - Sep-2005

    Keywords

    • PLACEBO-CONTROLLED TRIAL
    • SEROTONIN REUPTAKE INHIBITORS
    • PINDOLOL AUGMENTATION
    • DOUBLE-BLIND
    • ANTIDEPRESSANT TREATMENT
    • BIOMARKERS
    • COMBINATION
    • DEPRESSION
    • FLUOXETINE
    • RESISTANT

    Cite this